Quantitation by High Resolution Mass Spectrometry: Case Study of TOF MS for the Quantitation of Allopurinol from Human Plasma

Similar documents
Advancing your Forensic Toxicology Analyses; Adopting the Latest in Mass Spectrometry Innovations

LC-MS/MS Solutions for Comprehensive Cannabis Analysis

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Key Advantages of Comprehensive Cannabis Analysis

SCIEX Vitamin D 200M Assay for the Topaz System

Made For Routine Food, Environment, and Forensic Testing

Modernizing the Forensic Lab with LC-MS/MS Technology

Discovery Metabolomics - Quantitative Profiling of the Metabolome using TripleTOF Technology

High resolution mass spectrometry for bioanalysis at Janssen. Current experiences and future perspectives

Improving Selectivity in Quantitative Analysis Using MS 3 on a Hybrid Quadrupole-Linear Ion Trap Mass Spectrometer

Latest Innovations in LC/MS/MS from Waters for Metabolism and Bioanalytical Applications

Screening and Speciation of Raw and Processed Meat Products

Application Note # LCMS-89 High quantification efficiency in plasma targeted proteomics with a full-capability discovery Q-TOF platform

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

SelexION Technology for Lipid Analysis: Pushing the Boundaries of Lipidomics

Quantification of Budesonide Using UPLC and Xevo TQ-S

Towards High Resolution MS in Regulated Bioanalysis

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

Quantitative Analysis of -Hydroxybutyrate in Hair Using Target Analyte Finding Processing of Comprehensive GC-HRT Data

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

How to Use TOF and Q-TOF Mass Spectrometers

Identification of Ginsenosides Using the SCIEX X500R QTOF System

Identification & Confirmation of Structurally Related Degradation Products of Simvastatin

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

The Comparison of High Resolution MS with Triple Quadrupole MS for the Analysis of Oligonucleotides

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Run 1 Run 2 TDP PLP TDP PLP. 3.0e5 2.8e5 2.2e5. 2.6e5 2.4e5. 2.2e5 2.0e5. Intensity, cps. 1.8e5 1.6e5 1.4e5 1.2e5 1.0e5 4.0e4. 2.0e e5 1.

UPLC-HRMS: A tool for multi-residue veterinary drug methods

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

LC-MS/MS Method for the Determination of Tenofovir from Plasma

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

Mass Spectrometry Made Simple for Clinical Diagnostic Labs

Quadrupole and Ion Trap Mass Analysers and an introduction to Resolution

AbsoluteIDQ Kit: Targeted Metabolomics Identification and Quantification

Fast, Robust and Reliable Method for the Identification and Quantitation of Sildenafil Residue in Honey using LC-MS/MS

Amadeo R. Fernández-Alba

Impurity Identification using a Quadrupole - Time of Flight Mass Spectrometer QTOF

A Novel Platform of On-line Sample Pre-treatment and LC/MS/MS Analysis for Screening and Quantitation of Illicit Drugs in Urine

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

Abstract. Introduction

Reducing Sample Volume and Increasing Sensitivity for the Quantification of Human Insulin and 5 Analogs in Human Plasma Using ionkey/ms

Summary of Analytical Method for Quantitative Estimation of Fingolimod and Fingolimod Phosphate from Human Whole Blood Samples

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Vitamin D3 and related compounds by ESI and APCI

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Agilent 6490 Triple Quadrupole LC/MS System with ifunnel Technology. Ultra sensitive quantitative performance

Analysis of drugs of abuse in biological matrix using Time of Flight technology

Achieve Broad Lipid Quantitation using a High-Throughput Targeted Lipidomics Method

Overview. Introduction. Experimental. Cliquid Software for Routine LC/MS/MS Analysis

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

Real-time PK Measurement of the Chemotherapeutic Drug Melphalan in Whole Blood by a Novel PaperSpray Mass Spectrometry

Title: Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after. single oral administration to healthy Japanese volunteers

Targeted and untargeted metabolic profiling by incorporating scanning FAIMS into LC-MS. Kayleigh Arthur

Agilent s LC/MS Portfolio and Applications Examples

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Methods and Materials

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF

Overview. Introduction

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

LC-MS/MS for the quantification of Peptide biomarker and mixture of closely related Protein in formulation

Fully automated sensitive determination of immunosuppressant drugs in whole blood, using high quality internal standardization

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

Digitizing the Proteomes From Big Tissue Biobanks

Simple Method (IS-MRM) to Monitor Lysophospholipids and Phospholipids During LC-MS Method Development via In-Source CID

The New 6495 Triple Quadrupole LC/MS

Choosing the metabolomics platform

Bioanalytical Quantitation of Biotherapeutics Using Intact Protein vs. Proteolytic Peptides by LC-HR/AM on a Q Exactive MS

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

Agilent 6410 Triple Quadrupole LC/MS. Sensitivity, Reliability, Value

Meeting Challenging Requirements for the Quantitation of Regulated Growth Promoters Dexamethasone and Betamethasone in Liver and Milk

Determination of Selected Illegal Drugs and its Important Metabolites in Waste Water by Large Volume Direct Injection HPLC-MS/MS

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Drug development of highly potent therapeutic peptides Regulated microdose Bioanalysis

SYNAPT G2-S High Definition MS (HDMS) System

Polar Pesticides Method Update

vii LIST OF TABLES TABLE NO DESCRIPTION PAGE 1.1 System Suitability Parameters and Recommendations Acidic and Alkaline Hydrolysis 15

Pharmacologyonline 1: (2010) Newsletter Mohan et al.

LC/MS Biomarker Assay Validation Strategies Using Surrogate Matrix and Surrogate Analyte Approaches

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

Extraction of a Comprehensive Steroid Panel from Human Serum Using ISOLUTE. SLE+ Prior to LC/MS-MS Analysis

GC-MS/MS Analysis of Benzodiazepines Using Analyte Protectants

A High Sensitivity UPLC/MS/MS Method for the Analysis of Clopidogrel and Clopidogrel Carboxylic Acid Metabolite in Human K 2 EDTA Plasma

Transcription:

Quantitation by High Resolution Mass Spectrometry: Case Study of TOF MS for the Quantitation of Allopurinol from Human Plasma Shaokun Pang 1, Weixing Sun 2, Adrien Musuku 2, Xavier J. Misonne 1 1 SCIEX, Redwood City, CA; 2 Pharmascience Inc., Montreal, RUO-MKT-11-4490-A QC, Canada For Research Use Only. Not for use in diagnostic procedures.

Introduction Multiple reaction monitoring (MRM) methods has been the most popular tool in bioanalysis for the past two decades. Isobaric interferences present in complex matrices can be a challenge when they elute at or near the retention time of the analyte of interest in MRM chromatograms. The high resolution and mass accuracy on a Time-of-flight (TOF) MS provides better selectivity and can achieve higher signal-to-noise ratios (S/N) by filtering out interferences caused by isobaric compounds in the sample matrix. In addition to the targeted analyte signals, the rich TOF MS data can provide more information on matrix background, metabolites and interferences. This versatility provides users a valuable trouble-shooting tool and enables users to develop better methods 2 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

Allopurinol Assay In this study, we demonstrate the versatility of TOF data acquisition using the SCIEX TripleTOF 5600+ system in an assay of allopurinol Allopurinol is a medication used primarily to treat excess uric acid in the blood and its complications, including chronic gout. It is a xanthine oxidase inhibitor and is administered orally. An allopurinol assay was previously established on a SCIEX API 5000 TM system and 2 isobaric peaks were present in the MRM chromatogram of the analyte * * * Allopurinol Allopurinol- 13 C, 15 N 2 3 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

Allopurinol MRM Chromatograms Representative MRM chromatograms of blank plasma (A/B) and LLOQ (C/D) samples for Allopurinol 1.45 min (A and C) and its internal standard (B and D) 1.45 min. Allopurinol Allopurinol-IS Allopurinol Allopurinol-IS Isobaric endogenous compounds seen at 1.07 min and 2.43 min in the Allopurinol MRM chromatogram 4 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

Calibration Curve and Statistics of MRM Quantitation Calibration curve linear Quantitation range was 10 to 3200 ng/ml QC Statistics are shown below Sample Name Actual Mean Calculated Concentration Concentration (ng/ml) %CV Accuracy LLOQ 10.0 10.0 4.77% 100.00% QC A 30.0 30.7 2.39% 102.33% QC B 1600 1584 2.52% 99.02% QC C 3200 3108 1.97% 97.13% 5 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

Allopurinol TOF MS Chromatograms A different LC system was used for analysis on the SCIEX TripleTOF 5600+ system and retention times are shifted The peaks in the TOF MS chromatogram (A) were generated from an XIC (10 mda extraction width) of the parent ion m/z 135.031 and IS 138.029. Allopurinol elutes at 2.47 min (1.45 min in MRM) and the isobaric compounds at 1.45 min in the MRM at 2.21 min in the TOF MS chromatogram The isobaric compound at 2.43 min in the MRM chromatogram is not present in the TOF MS chromatogram A new compound at 1.12 min is revealed in the TOF MS XIC Allopurinol MRM TOF MS 6 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

Allopurinol TOF MS Quantitation A calibration curve and QC samples were run on the SCIEX TripleTOF 5600+ system and the TOF MS XIC of Allopurinol and Allopurinol-IS were used to build the calibration curve Calibration Standard Statistics QC Sample Statistics Quantitation using TOF MS gave matching precision, accuracy, and linearity to the nominal resolution triple-quad MS. 7 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

Allopurinol TOF Product Ion Chromatograms (MRM HR ) The peaks in the TOF product ion (MRM HR ) chromatogram (B) were generated from an XIC (10 mda extraction width) of the product ion m/z 92.026 Allopurinol elutes at 2.47 min (1.45 min in MRM) and the isobaric compounds at 2.21 and 3.15 minutes The new compound at 1.12 min revealed in the TOF MS XIC is not present in the MRM HR chromatogram Allopurinol MRM TOF Product Ion B Allopurinol 8 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

Allopurinol MRM HR Quantitation The TOF Product Ion XIC (MRM HR ) of Allopurinol 92.026 and Allopurinol-IS were used to build the calibration curve Calibration Standard Statistics QC Sample Statistics The calibration curve for quantitation using TOF Product Ion XIC (MRM HR ) was concave in shape and required a polynomial fit The polynomial fit gave acceptable precision and accuracy to the TOF MS and nominal resolution triple-quad MS. 9 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

TOF MS Spectra of Allopurinol The 3.15 min isobaric peak (B) was eliminated from the TOFMS XIC due to its molecular ion (135.0456) larger-than ±0.005 Da (D) B The Allopurinol molecular ion has an m/z of 135.0309 (C). TOF MS Allopurinol TOF MS 10 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

TOF Product Ion Spectra of Allopurinol The compound at 1.12 min revealed in the TOF MS XIC (A) is not present in the MRM HR chromatogram because there is no product ion signal at 92.023 (E). TOF Product Ion 11 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

MRM HR Quantitation The MRM HR standard curve was concave in shape, which is characteristic of a constant systematic contribution of intensity (background) in the chromatogram In the background there is also a contribution of 135.0 92.026 as shown on left This background intensity in MRM HR affects the linearity of the calibration curve at low concentrations and results in the concave shape Background intensity in MRM HR (1.5 to 1.7 min) This low mass background contribution was not significant on the SCIEX API 5000 TM system 12 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

Summary In this case study, we have demonstrated that the TOF MS instrument is able to conduct a bioanalytical assay with matching precision, accuracy, and linearity to a nominal resolution triple-quad MS. Analysts have a choice of using either MS or MS/MS data to quantify the analyte. TOF data (MS and MS/MS) will provide additional specificity in addition to the specificity from high resolution. Beyond the quantitation capability, and unlike MRM data, TOF data also provides more information during method development for users to trouble-shoot issues that could interfere with the method and/or the results 13 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.

Trademarks/Licensing AB Sciex is doing business as SCIEX. For Research Use Only. Not for use in diagnostic procedures. 2016 AB Sciex. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEX is being used under license. 14 2016 AB Sciex RUO-MKT-11-4490-A For Research Use Only. Not for use in diagnostic procedures.